"Build quality in"--HER2 testing in the real world.
Zujewski
Jo Anne
JA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D000075202:Contraindications; D003951:Diagnostic Errors; D006801:Humans; D018579:Patient Selection; D011379:Prognosis; D011787:Quality of Health Care; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis* / Q000235:genetics / Q000378:metabolism; D015203:Reproducibility of Results; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab